Alexey Andreevich Shmonin

Alexey Andreevich Shmonin

Auto-generated profile, based on publicly available information

Alexey Andreevich Shmonin

Pavlov First Saint Petersburg State Medical University

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in The Lancet Neurology
Verified
Journal Article
Closed access
SKScott E Kasner
Scott E Kasner
BSBalakumar Swaminathan
Balakumar Swaminathan
PLPablo Lavados
Pablo Lavados
MSMukul Sharma
Mukul Sharma
KMKeith Muir
Keith Muir
JZJ Zwiernik
J Zwiernik

1 May 2014 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
Maxim ShevtsovMaxim Shevtsov
Maxim Shevtsov
BNBoris P Nikolaev
Boris P Nikolaev
LYLudmila Y Yakovleva
Ludmila Y Yakovleva
ADAnatoliy Dobrodumov
Anatoliy Dobrodumov
ADAnastasiy S Dayneko
Anastasiy S Dayneko
BMBoris A Margulis
Boris A Margulis
Recombinant 70 kDa heat shock protein (Hsp70) is an antiapoptotic protein that has a cell protective activity in stress stimuli and thus could be a useful therapeutic agent in the management of patients with acute ischemic stroke. The neuroprotective and neurotherapeutic activity of recombinant Hsp70 was explored in a model of experimental stroke in rats. Ischemia was produced by the occlusion of the middle cerebral artery for 45 minutes. To assess its neuroprotective capacity, Hsp70, at various concentrations, was intravenously injected 20 minutes prior to ischemia. Forty-eight hours after ischemia, rats were sacrificed and brain tissue sections were stained with 2% triphenyl tetrazolium chloride. Preliminary treatment with Hsp70 significantly reduced the ischemic zone (optimal response at 2.5 mg/kg). To assess Hsp70’s neurotherapeutic activity, we intravenously administered Hsp70 via the tail vein 2 hours after reperfusion (2 hours and 45 minutes after ischemia). Rats were then kept alive for 72 hours. The ischemic region was analyzed using a high-field 11 T MRI scanner. Administration of the Hsp70 decreased the infarction zone in a dose-dependent manner with an optimal (threefold) therapeutic response at 5 mg/kg. Long-term treatment of the ischemic rats with Hsp70 formulated in alginate granules with retarded release of protein further reduced the infarct volume in the brain as well as apoptotic area (annexin V staining). Due to its high neurotherapeutic potential, prolonged delivery of Hsp70 could be useful in the management of acute ischemic stroke.

1 March 2008 in Cardiovascular & Hematological Disorders-Drug Targets
Verified
Journal Article
Closed access
PDF file
MGMichael Galagudza
Michael Galagudza
IBIlia O. Blokhin
Ilia O. Blokhin
ASAleksey A. Shmonin
Aleksey A. Shmonin
KMKirill A. Mischenko
Kirill A. Mischenko
Reduction of infarct size as well as alleviation of other ischemia- and reperfusion-associated injuries are the goals of primary importance in cardiology. One of the remedies is considered to be myocardial preconditioning (PreCon) referred usually to as an increased myocardial tolerance to prolonged ischemia following brief ischemic or non-ischemic challenge. In this review, PreCon stimuli tested to date are considered including a number of mildly noxious factors applied either locally to the myocardium or systemically. Recently, one more mode of heart protection against reperfusion injury termed postconditioning (PostCon) has been developed. On the basis of ample evidence published, along with our findings, a detailed comparative analysis of PreCon and PostCon is presented, with special emphasis on the cellular, molecular, and pharmacological aspects of the topic as well as clinical applications, both implemented and awaiting practical approval.

7 July 2020 in Physical and rehabilitation medicine, medical rehabilitation
Verified
Journal Article
Open access
PDF file
GIGalina E. Ivanova
Galina E. Ivanova
IBIrina N. Balandina
Irina N. Balandina
IBIrina S. Bakhtina
Irina S. Bakhtina
ABAndrey A. Belkin
Andrey A. Belkin
ABAnatoly F. Belyaev
Anatoly F. Belyaev
ASAlexey A. Shmonin
Alexey A. Shmonin
The emergence of SARS-CoV-2 and its worldwide spread has become a challenge for healthcare professionals related to rapid diagnosis of infection caused by the new coronaviruses, provision of specialized medical care, rehabilitation and secondary prevention. Currently, there is limited information on primary, secondary prevention and medical rehabilitation of this disease. The most common clinical manifestation of the new variant of coronavirus infection is bilateral pneumonia, with 34% of patients developing acute respiratory distress syndrome (ARDS). Given the unusual pandemic situation and the peculiar COVID-19 pathogenesis, the stereotyped application of generally accepted methods may be unsafe or ineffective. The Union of Rehabilitologists of Russia has prepared Temporary guidelines that are based on the advice on medical rehabilitation of patients with COVID-19 at various stages of special medical care published by WHO specialists, analysis of reports from clinics currently involved in rehabilitation of COVID-19 patients, as well as on the results of clinical studies conducted earlier on the rehabilitation of patients with Post-intensive care syndrome and adult respiratory distress syndrome (ARDS) of non-coronavirus etiology, regulatory documents of the Russian Ministry of Health and Federal Service on Surveillance for Consumer rights protection and human well-being. A syndrome-based approach to the use of means and methods of physical and rehabilitation medicine is also considered. The guidelines are intended for heads of medical organizations and their structural divisions, general practitioners, physicians, infectious disease doctors, pediatricians, emergency physicians of intensive care units in infectious hospitals, physiotherapy and sports medicine doctors, physiotherapists, medical psychologists, physical therapy instructors, nurses and other specialists of multidisciplinary rehabilitation teams working in the field of medical care for patients with COVID-19 at various stages.

22 February 2024 in Neurology, Neuropsychiatry, Psychosomatics
Verified
Journal Article
Open access
PDF file
GIG. E. Ivanova
G. E. Ivanova
NKN. L. Kunelskaya
N. L. Kunelskaya
VPVladimir Parfenov
Vladimir Parfenov
MZM. V. Zamergrad
M. V. Zamergrad
OMO. A. Melnikov
O. A. Melnikov
MMM. N. Maltseva
M. N. Maltseva
Experts discussed the problem of comprehensive medical treatment of vertigo through vestibular rehabilitation. Peripheral vestibular vertigo is most commonly caused by benign paroxysmal positional vertigo, Meniere's disease and vestibular neuronitis, while central vestibular vertigo is caused by vestibular migraine and stroke. Vestibular rehabilitation is one of the most effective areas of treatment for patients with various disorders of the vestibular system characterized by chronic dizziness. Vestibular rehabilitation improves patients' walking and stability and can lead to an improvement in patients' daily activities and quality of life. Currently, in our country medical rehabilitation centres are being established where patients with various causes of vestibular vertigo can receive complex therapy, including vestibular rehabilitation. The Expert Council recommends the comprehensive personalised use of vestibular rehabilitation in the complex treatment of various diseases manifested by dizziness. An educational program is needed for neurologists, ENT specialists and rehabilitation specialists in treatment of patients with different types of vestibular dizziness.

8 June 2020 in Physical and rehabilitation medicine, medical rehabilitation
Verified
Journal Article
Open access
GIGalina Evgenievna Ivanova
Galina Evgenievna Ivanova
ASAlexey Andreevich Shmonin
Alexey Andreevich Shmonin
MMMaria Nikolaevna Maltseva
Maria Nikolaevna Maltseva
IMIrina Evgenievna Mishina
Irina Evgenievna Mishina
EMElena Valentinovna Melnikova
Elena Valentinovna Melnikova
MDMikhail D. Didur
Mikhail D. Didur
Patients with a new coronavirus infection (COVID-19) need rehabilitation. Rehabilitation approaches of patients with another pathology also require to be reviewed under the conditions of the SARS-CoV-2 epidemic. It is necessary to develop clinical recommendations for the rehabilitation care delivery in patients with COVID-19 and other diseases during a pandemic. A group of experts analyzed the data of current reviews on rehabilitation with COVID-19, as well as previous studies on rehabilitation in patients with Post-intensive care syndrome (PICS) and acute respiratory distress syndrome of non-coronavirus etiology, and developed thereupon the main positions of clinical recommendations. We discuss the main rehabilitation problems in patients with COVID-19, in particular structures and functions impairments, leading to limitations and restrictions of self-care, mobility, domestic life, communication, interpersonal interactions and relationships, professional activities and those determining care requirement. The article also provides general recommendations on medical rehabilitation management in a pandemic at all three stages, including patients routing, ensuring the infectious safety of medical personnel and patients. The necessary individual rehabilitation program components for patients with COVID-19 at all stages of rehabilitation have been identified, including patients examination, nutritional deficiency correction, restoration of respiratory function, exercise tolerance, muscle strength, self-monitoring and training in new movement conditions, psychoemotional state disorders and cognitive functions, as well as independence in everyday life recovery. Medical rehabilitation during the COVID-19 epidemic should include all rehabilitation care components and helps to optimize vital functions, to prevent complications and to improve the patients life quality.